The Foundation’s commitment to these principles will continue to be a cornerstone of the Foundation’s work to advance our mission in 2023.
Site Search
Showing 1 - 5 of 5 results
News
|
|
4 min read
The Cystic Fibrosis Foundation’s investment will go toward conducting preclinical research on a novel gene delivery vehicle. If successful, this gene delivery method could overcome some of the biggest challenges to delivering a gene therapy into the lung cells of people with cystic fibrosis.
News
|
|
2 min read
Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
News
|
|
2 min read
This year’s program marked the largest in-person advocacy event in the Foundation’s history.
News
|
|
3 min read
Revised approach to lung function reporting is shown to be more scientifically accurate and may reduce health disparities.
News
|
|
5 min read